marijuana stocks

GW Pharmaceuticals Continues To Rally: A Technical Look

GW Pharmaceuticals Plc (NASDAQ:GWPH) shares were trading higher by $2.20 (2.5 percent) at $97.86 in Monday’s session. The darling of the marijuana sector is following through on Friday’s impressive nearly $11.00 rally ($84.58 to $95.66). It should be noted Friday’s rally took place on extremely high volume for the issue of nearly two million shares vs. its 20-day average of 325,000.

Investors may be anticipating positive results as the company is set to release additional Epidiolex data at the American Academy of Neurology that should inform developments in other orphan epilepsy. Over the past year, the issue has fluctuated primarily based on news concerning the drug and not so much on developments related to marijuana.

See Also: 15 Marijuana Stocks To Watch In 2015

After a bit off profit-taking off the open, it quickly found support just $0.16 from its opening price ($94.23 vs. $94.39) before ripping north once again. At time of writing, it easily surpassed Friday’s high ($95.92), reaching $98.43 before taking a breather.

The all-time high for the issue was made in July 2014, at the pinnacle of the “pot stock” mania at $111.46, before cascading to $58.16 in October.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Aurora Cannabis Inc. (ACB) Announces Operational & Balance Sheet Improvements

Aurora Cannabis Announces Operational & Balance Sheet Improvements Aurora Cannabis Inc. (the…

Ascend Wellness Holdings, Inc. (AAWH) to Hold First Quarter 2022 Earnings Conference Call on Wednesday, May 11, 2022

AWH to Hold First Quarter 2022 Earnings Conference Call on Wednesday, May…

$AFI Dr. Kaleb Lund Awarded Research Grant From Bastyr University

Dr. Kaleb Lund of Herbal Analytics Awarded Research Grant From Bastyr University…

$GWPH Makes Dravet Syndrome Very Afraid!

GW Pharmaceuticals Announces Epidiolex(R) Receives Orphan Designation From European Medicines Agency for…